Moreover, CD39 is up‐regulated in Tregs from all layers of the tumour–adjacent bowel wall as well as tumour tissue, indicating its pro‐tumour role in the peri‐tumoural or intra‐tumoural regions during CRC progression. The gene discussed is ENTPD1; the disease is colorectal carcinoma.